These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33638687)

  • 1. Efficacy and safety of irreversible electroporation for malignant liver tumors: a systematic review and meta-analysis.
    Gupta P; Maralakunte M; Sagar S; Kumar-M P; Bhujade H; Chaluvashetty SB; Kalra N
    Eur Radiol; 2021 Sep; 31(9):6511-6521. PubMed ID: 33638687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-center nonrandomized clinical trial to assess the safety and efficacy of irreversible electroporation (IRE) ablation of liver tumors in humans: Short to mid-term results.
    Frühling P; Nilsson A; Duraj F; Haglund U; Norén A
    Eur J Surg Oncol; 2017 Apr; 43(4):751-757. PubMed ID: 28109674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Irreversible Electroporation for the Treatment of Hepatocellular Carcinoma Not Amenable to Thermal Ablation Techniques: A Retrospective Single-Center Case Series.
    Sutter O; Calvo J; N'Kontchou G; Nault JC; Ourabia R; Nahon P; Ganne-Carrié N; Bourcier V; Zentar N; Bouhafs F; Sellier N; Diallo A; Seror O
    Radiology; 2017 Sep; 284(3):877-886. PubMed ID: 28453431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous Irreversible Electroporation (IRE) of Hepatic Malignancy: A Bi-institutional Analysis of Safety and Outcomes.
    Mafeld S; Wong JJ; Kibriya N; Stenberg B; Manas D; Bassett P; Aslam T; Evans J; Littler P
    Cardiovasc Intervent Radiol; 2019 Apr; 42(4):577-583. PubMed ID: 30465255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of irreversible electroporation in unresectable perihilar cholangiocarcinoma: a systematic review and meta-analysis.
    Scrofani AR; Valvano M; Lancellotta V; Pezzulla D; Vinci A; Cornacchione P; Bonome P; Tagliaferri L; Iezzi R
    Br J Radiol; 2024 Aug; 97(1160):1413-1422. PubMed ID: 38775716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermal ablation in the treatment of intrahepatic cholangiocarcinoma: a systematic review and meta-analysis.
    Kim GH; Kim PH; Kim JH; Kim PN; Won HJ; Shin YM; Choi SH
    Eur Radiol; 2022 Feb; 32(2):1205-1215. PubMed ID: 34347159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Midterm Safety and Efficacy of Irreversible Electroporation of Malignant Liver Tumors Located Close to Major Portal or Hepatic Veins.
    Distelmaier M; Barabasch A; Heil P; Kraemer NA; Isfort P; Keil S; Kuhl CK; Bruners P
    Radiology; 2017 Dec; 285(3):1023-1031. PubMed ID: 28799842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irreversible Electroporation for Unresectable Hepatocellular Carcinoma: Initial Experience.
    Kalra N; Gupta P; Gorsi U; Bhujade H; Chaluvashetty SB; Duseja A; Singh V; Dhiman RK; Chawla YK; Khandelwal N
    Cardiovasc Intervent Radiol; 2019 Apr; 42(4):584-590. PubMed ID: 30697637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Safety and Efficacy of Locoregional Therapy Combined with Adoptive Transfer of Allogeneic γδ T Cells for Advanced Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
    Zhang T; Chen J; Niu L; Liu Y; Ye G; Jiang M; Qi Z
    J Vasc Interv Radiol; 2022 Jan; 33(1):19-27.e3. PubMed ID: 34600129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Locoregional options in the management of cholangiocarcinoma: single center experience.
    Baydoun H; Meirovich H; Maroun G; Coburn N; David E
    Ann Palliat Med; 2021 Feb; 10(2):1784-1791. PubMed ID: 33725764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irreversible electroporation for liver cancer ablation: A meta analysis.
    Yu M; Li S
    Eur J Surg Oncol; 2022 Jun; 48(6):1321-1330. PubMed ID: 35012834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ablation of Locally Advanced Pancreatic Cancer with Percutaneous Irreversible Electroporation: Results of the Phase I/II PANFIRE Study.
    Scheffer HJ; Vroomen LG; de Jong MC; Melenhorst MC; Zonderhuis BM; Daams F; Vogel JA; Besselink MG; van Kuijk C; Witvliet J; de van der Schueren MA; de Gruijl TD; Stam AG; van den Tol PM; van Delft F; Kazemier G; Meijerink MR
    Radiology; 2017 Feb; 282(2):585-597. PubMed ID: 27604035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response evaluation of locoregional therapies in combined hepatocellular-cholangiocarcinoma and intrahepatic cholangiocarcinoma versus hepatocellular carcinoma: a propensity score matched study.
    Mukund A; V Srinivasan S; Rana S; Vijayaraghavan R; Patidar Y; Arora V; Jindal A; Choudhury A; Shasthry SM; Sarin SK
    Clin Radiol; 2022 Feb; 77(2):121-129. PubMed ID: 34789395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: a promising treatment.
    Lin M; Liang S; Wang X; Liang Y; Zhang M; Chen J; Niu L; Xu K
    J Cancer Res Clin Oncol; 2017 Dec; 143(12):2607-2618. PubMed ID: 28871458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irreversible Electroporation Can Effectively Ablate Hepatocellular Carcinoma to Complete Pathologic Necrosis.
    Cheng RG; Bhattacharya R; Yeh MM; Padia SA
    J Vasc Interv Radiol; 2015 Aug; 26(8):1184-8. PubMed ID: 26119204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irreversible electroporation of hepatocellular carcinoma and colorectal cancer liver metastases: A nationwide multicenter study with short- and long-term follow-up.
    Frühling P; Stillström D; Holmquist F; Nilsson A; Freedman J
    Eur J Surg Oncol; 2023 Nov; 49(11):107046. PubMed ID: 37716017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodal therapy with or without irreversible electroporation for unresectable locally advanced pancreatic adenocarcinoma: a systematic review and meta-analysis.
    Sugumar K; Hurtado A; Naik I; Hue JJ; Rothermel LD; Ammori JB; Hardacre JM; Winter JM; Ocuin LM
    HPB (Oxford); 2022 May; 24(5):586-595. PubMed ID: 35000842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Safety and Efficacy of Irreversible Electroporation for Large Hepatocellular Carcinoma.
    Zeng J; Liu G; Li ZH; Yang Y; Fang G; Li RR; Xu KC; Niu L
    Technol Cancer Res Treat; 2017 Feb; 16(1):120-124. PubMed ID: 27837054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irreversible electroporation versus radiofrequency ablation for hepatocellular carcinoma: a single centre propensity-matched comparison.
    Freeman E; Cheung W; Ferdousi S; Kavnoudias H; Majeed A; Kemp W; Roberts SK
    Scand J Gastroenterol; 2021 Aug; 56(8):942-947. PubMed ID: 34057003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irreversible Electroporation For Hepatocellular Carcinoma: Longer-Term Outcomes At A Single Centre.
    Freeman E; Cheung W; Kavnoudias H; Majeed A; Kemp W; Roberts SK
    Cardiovasc Intervent Radiol; 2021 Feb; 44(2):247-253. PubMed ID: 33051707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.